ARCHIVES

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 8 | August 26, 2005

Download PDF Visit The Full Archive

Related Articles

As Bristol’s Final Defenses Fall, IVAX Prepares Launch Of Generic Paclitaxel.

October 20, 2000

Sequestration Delayed For Two Months While Congress Debates Debt and Budgets

January 4, 2013

Congress enacts Medicare reform, bill cuts oncology reimbursement.

November 28, 2003

NCI Revises Procedure for Contract Concept Review By Advisors

September 6, 1996

Funding Opportunities

September 20, 2002

NCI Plans 3 Percent Across-The-Board Cut To Pool Funds For High Priorities In FY08.

September 21, 2007